Management of UTI in a Patient on Nitrofurantoin Prophylaxis

Assessment and Treatment

The patient presents with increased urinary frequency without dysuria, positive leukocytes and trace protein on urinalysis, suggesting a breakthrough urinary tract infection despite being on nitrofurantoin prophylaxis, indicating the need for a different antibiotic to treat the current infection, as recommended by the European Urology guidelines 1, 2
The absence of fever or other systemic symptoms indicates this is likely an uncomplicated lower UTI rather than pyelonephritis, according to the European Urology guidelines 3
Fosfomycin trometamol 3g single dose is recommended as the most appropriate treatment option, providing a different mechanism of action than the current prophylactic agent, improving compliance, and being effective against many nitrofurantoin-resistant organisms, as recommended by the European Urology and JAMA network open guidelines 1, 2
Alternative options include Trimethoprim-sulfamethoxazole 160/800mg twice daily for 3 days, if local resistance patterns permit, and Cephalosporins, such as cefadroxil 500mg twice daily for 3 days, if local E. coli resistance is <20%, as recommended by the European Urology and JAMA network open guidelines 1, 2

Urine culture should be obtained before starting new antibiotics to guide therapy if symptoms don't resolve, as recommended by the European Urology guidelines 1
If symptoms do not resolve within 4 weeks of treatment completion or recur within 2 weeks, perform urine culture with antimicrobial susceptibility testing, as recommended by the European Urology guidelines 1
Consider reevaluating the effectiveness of the current prophylactic regimen after treating the acute infection, as recommended by the JAMA network open guidelines 2
After treating the current infection, evaluate whether continuing nitrofurantoin prophylaxis is appropriate, considering alternatives if breakthrough infections continue, such as immunoactive prophylaxis, vaginal estrogen replacement for postmenopausal women, and increased fluid intake to reduce recurrent UTI risk, as recommended by the European Urology guidelines 1

The European Association of Urology recommends not performing extensive workup, such as cystoscopy or abdominal ultrasound, in women younger than 40 with recurrent UTI without risk factors, as stated in the European Urology guidelines 1
Nitrofurantoin is contraindicated in patients with creatinine clearance <60 mL/min due to inadequate urinary drug concentrations and increased toxicity risk, as noted in the Praxis Medical Insights guidelines, but prioritizing the European Urology guidelines 1